Acadia Pharmaceuticals | ACAD - Zahlungsmittel Und Äquivalente

Aktienkurs
20.73
Täglich Wechseln
0.01 0.05%
Monatlich
-16.17%
Jährlich
23.47%
Q1 Prognose
19.99




Zahlungsmittel Und Äquivalente Veränderung Datum
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cara Therapeutics USD 20.65M 13.57M 2025-06
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Cytokinetics USD 122.52M 102.95M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Incyte USD 3.58B 650.78M 2025-12
J&J USD 19.71B 1.48B 2025-12
Moderna USD 2.6B 1.46B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pfizer USD 1.34B 295M 2025-09
Prothena USD 307.53M 23.31M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12